I-Mab ADR (IMAB) Social Stream
I-MAB (IMAB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering I-MAB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 7 | $95 | $85 | $90.3 | $2.07 | 4262.32% |
| 2022-02-09 | 6 | $95 | $85 | $90.3 | $2.07 | 4262.32% |
| 2022-03-30 | 6 | $95 | $76 | $82.133 | $2.07 | 3867.78% |
| 2022-05-31 | 7 | $95 | $35 | $72.966 | $2.07 | 3424.93% |
| 2022-08-13 | 6 | $95 | $35 | $72.966 | $2.07 | 3424.93% |
| 2022-08-30 | 6 | $95 | $35 | $59.133 | $2.07 | 2756.67% |
| 2023-01-26 | 5 | $64.6 | $25 | $39.1 | $2.07 | 1788.89% |
| 2023-04-03 | 6 | $64.6 | $25 | $32.933 | $2.07 | 1490.97% |
| 2023-07-11 | 5 | $64.6 | $24 | $31.433 | $2.07 | 1418.5% |
| 2023-08-18 | 6 | $25 | $2.9 | $21.15 | $2.07 | 921.74% |
| 2023-09-25 | 5 | $23 | $2.9 | $15.38 | $2.07 | 643% |
The Trend in the Analyst Price Target
IMAB's average price target has moved down $20.6 over the prior 13 months.
IMAB reports an average of 986.07% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 5 | 64.6 | 25 | 39.100 | 6.41 | 509.98% |
| 2023-04-03 | 6 | 64.6 | 24 | 31.433 | 3.68 | 754.16% |
| 2023-04-03 | 6 | 64.6 | 25 | 32.933 | 3.68 | 794.92% |
| 2023-09-25 | 4 | 23.0 | 15 | 18.500 | 1.28 | 1345.31% |
| 2023-09-25 | 5 | 23.0 | 15 | 18.500 | 1.28 | 1345.31% |
IMAB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 3 | 1 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 16 months, IMAB's average broker recommendation rating worsened by 0.06.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMAB as an investment opportunity.
- I-MAB's upside potential (average analyst target price relative to current price) is higher than 2154.43% of all US stocks.
- In the context of stocks in the mid market cap category, I-MAB's variance in analysts' estimates is lower than -1415.22% of them.
- In the context of stocks in the mid market cap category, I-MAB's number of analysts covering the stock is greater than 624.78% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, I-MAB's average analyst price target is greater than 1130.36% of them.
Stocks similar to I-MAB in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IGMS, KRTX, and BBIO.
View All Top Stocks by Price Target
Is IMAB a Buy, Hold or Sell? See the POWR Ratings now!